| 4.6 |
23.1 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
| 4.6 |
13.8 |
GO:0021998 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
| 4.6 |
4.6 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 4.5 |
4.5 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 4.3 |
17.0 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 4.2 |
12.7 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 4.1 |
12.4 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 3.9 |
11.8 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 3.9 |
11.6 |
GO:0030421 |
defecation(GO:0030421) |
| 3.4 |
3.4 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 3.4 |
10.1 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 3.2 |
9.5 |
GO:0014028 |
notochord formation(GO:0014028) |
| 3.1 |
12.5 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 2.9 |
5.9 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 2.9 |
2.9 |
GO:0061180 |
mammary gland epithelium development(GO:0061180) |
| 2.8 |
17.1 |
GO:0003383 |
apical constriction(GO:0003383) |
| 2.7 |
10.7 |
GO:0098868 |
endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
| 2.6 |
2.6 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 2.6 |
2.6 |
GO:1904672 |
regulation of somatic stem cell population maintenance(GO:1904672) |
| 2.4 |
7.3 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 2.4 |
21.7 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 2.4 |
2.4 |
GO:1990776 |
cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
| 2.4 |
9.4 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 2.4 |
7.1 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 2.3 |
11.4 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 2.3 |
6.8 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 2.3 |
2.3 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 2.2 |
6.7 |
GO:1904395 |
positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 2.1 |
12.8 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 2.1 |
6.4 |
GO:0003360 |
brainstem development(GO:0003360) |
| 2.1 |
8.5 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 2.1 |
10.6 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 2.1 |
8.3 |
GO:0060857 |
establishment of glial blood-brain barrier(GO:0060857) |
| 2.1 |
6.2 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 2.1 |
2.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 2.0 |
6.1 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 2.0 |
4.0 |
GO:0001743 |
optic placode formation(GO:0001743) |
| 2.0 |
6.0 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 2.0 |
4.0 |
GO:0060849 |
regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 2.0 |
4.0 |
GO:2000974 |
negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
| 2.0 |
4.0 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) |
| 2.0 |
13.7 |
GO:1902965 |
regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 1.9 |
11.2 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 1.9 |
20.5 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 1.8 |
5.5 |
GO:1904719 |
excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 1.8 |
14.5 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 1.8 |
7.2 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 1.8 |
7.2 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 1.8 |
8.8 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 1.8 |
19.4 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 1.7 |
5.2 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 1.7 |
1.7 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 1.7 |
5.1 |
GO:1990859 |
cellular response to endothelin(GO:1990859) |
| 1.7 |
17.0 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 1.7 |
1.7 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.7 |
3.3 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) |
| 1.6 |
4.9 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 1.6 |
6.3 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 1.6 |
7.9 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 1.6 |
3.1 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 1.5 |
4.6 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 1.5 |
3.1 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 1.5 |
9.1 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 1.5 |
6.0 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 1.5 |
5.9 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 1.5 |
5.9 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 1.5 |
10.3 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 1.5 |
1.5 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 1.5 |
4.4 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 1.5 |
4.4 |
GO:0021972 |
corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 1.5 |
4.4 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 1.5 |
2.9 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 1.5 |
1.5 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 1.5 |
5.8 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 1.4 |
13.0 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 1.4 |
5.7 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 1.4 |
14.3 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 1.4 |
7.1 |
GO:0038027 |
apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 1.4 |
12.7 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 1.4 |
2.8 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 1.4 |
1.4 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 1.4 |
55.7 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 1.4 |
6.9 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 1.3 |
4.0 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.3 |
5.4 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 1.3 |
9.4 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 1.3 |
18.4 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 1.3 |
2.6 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 1.3 |
2.6 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 1.3 |
3.9 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 1.3 |
6.4 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 1.3 |
1.3 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 1.2 |
3.7 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 1.2 |
2.5 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 1.2 |
4.9 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
| 1.2 |
3.7 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 1.2 |
6.1 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 1.2 |
1.2 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 1.2 |
3.6 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 1.2 |
1.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 1.2 |
1.2 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 1.2 |
4.8 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 1.2 |
7.1 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 1.2 |
10.6 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 1.2 |
3.5 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 1.1 |
1.1 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 1.1 |
5.7 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 1.1 |
1.1 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 1.1 |
3.4 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 1.1 |
10.1 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 1.1 |
1.1 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 1.1 |
2.2 |
GO:0033864 |
positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 1.1 |
1.1 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 1.1 |
3.3 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 1.1 |
1.1 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 1.1 |
6.6 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 1.1 |
3.3 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 1.1 |
3.3 |
GO:0051316 |
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
| 1.1 |
4.4 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 1.1 |
4.4 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 1.1 |
1.1 |
GO:2000137 |
negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
| 1.1 |
9.8 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 1.1 |
3.3 |
GO:0071579 |
regulation of zinc ion transport(GO:0071579) |
| 1.1 |
9.8 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 1.1 |
7.6 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 1.1 |
5.3 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 1.1 |
4.2 |
GO:0046655 |
folic acid metabolic process(GO:0046655) |
| 1.1 |
5.3 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 1.1 |
7.4 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 1.1 |
5.3 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 1.1 |
2.1 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 1.0 |
3.1 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 1.0 |
1.0 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 1.0 |
3.0 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 1.0 |
2.0 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
| 1.0 |
1.0 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 1.0 |
7.0 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 1.0 |
7.9 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 1.0 |
10.8 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 1.0 |
1.0 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 1.0 |
1.0 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 1.0 |
5.8 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 1.0 |
2.9 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 1.0 |
2.9 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 1.0 |
2.9 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 1.0 |
2.9 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.9 |
2.8 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.9 |
3.8 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.9 |
4.7 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.9 |
3.7 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.9 |
0.9 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.9 |
3.7 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.9 |
6.5 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.9 |
1.8 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.9 |
0.9 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) |
| 0.9 |
13.7 |
GO:0010715 |
regulation of extracellular matrix disassembly(GO:0010715) |
| 0.9 |
0.9 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.9 |
2.7 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.9 |
0.9 |
GO:0035561 |
regulation of chromatin binding(GO:0035561) |
| 0.9 |
6.4 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.9 |
10.0 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.9 |
3.6 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.9 |
1.8 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.9 |
1.8 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.9 |
0.9 |
GO:1904393 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
| 0.9 |
14.2 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.9 |
15.0 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.9 |
3.5 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.9 |
7.9 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.9 |
2.6 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.9 |
3.5 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.9 |
2.6 |
GO:0060558 |
regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
| 0.9 |
13.0 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.9 |
2.6 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) |
| 0.9 |
6.9 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.9 |
4.3 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.9 |
0.9 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.9 |
0.9 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.8 |
0.8 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.8 |
3.4 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.8 |
2.5 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.8 |
6.7 |
GO:0051383 |
kinetochore organization(GO:0051383) |
| 0.8 |
2.5 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.8 |
13.4 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.8 |
0.8 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.8 |
0.8 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.8 |
1.7 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.8 |
11.5 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.8 |
1.6 |
GO:0072236 |
metanephric loop of Henle development(GO:0072236) |
| 0.8 |
3.3 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.8 |
3.2 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.8 |
1.6 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 0.8 |
2.4 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.8 |
4.0 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.8 |
2.4 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) response to folic acid(GO:0051593) |
| 0.8 |
7.9 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.8 |
5.5 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.8 |
7.9 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.8 |
3.1 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.8 |
2.4 |
GO:2000054 |
regulation of chondrocyte development(GO:0061181) regulation of centromeric sister chromatid cohesion(GO:0070602) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 0.8 |
7.8 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.8 |
2.3 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 0.8 |
12.4 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) |
| 0.8 |
2.3 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.8 |
1.5 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.8 |
3.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.8 |
2.3 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.8 |
0.8 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.8 |
12.9 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.8 |
0.8 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.8 |
2.3 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.8 |
2.3 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.8 |
4.5 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.8 |
3.8 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.8 |
2.3 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.8 |
4.5 |
GO:0046070 |
dGTP metabolic process(GO:0046070) |
| 0.7 |
4.5 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.7 |
7.5 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.7 |
2.2 |
GO:1905223 |
epicardium morphogenesis(GO:1905223) |
| 0.7 |
3.7 |
GO:0044838 |
cell quiescence(GO:0044838) |
| 0.7 |
2.2 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.7 |
4.4 |
GO:0090005 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.7 |
0.7 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.7 |
1.5 |
GO:0042320 |
regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.7 |
2.2 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.7 |
4.3 |
GO:0032196 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 0.7 |
0.7 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.7 |
0.7 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.7 |
5.0 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.7 |
1.4 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.7 |
2.1 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.7 |
4.3 |
GO:2000561 |
CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
| 0.7 |
0.7 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.7 |
2.1 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.7 |
4.9 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.7 |
2.1 |
GO:0045819 |
plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
| 0.7 |
0.7 |
GO:0002200 |
somatic diversification of immune receptors(GO:0002200) |
| 0.7 |
2.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.7 |
2.1 |
GO:2000637 |
positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.7 |
17.2 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.7 |
7.5 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.7 |
2.7 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.7 |
2.1 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.7 |
0.7 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.7 |
2.0 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.7 |
4.8 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.7 |
0.7 |
GO:2000416 |
regulation of eosinophil migration(GO:2000416) |
| 0.7 |
2.0 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.7 |
2.7 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.7 |
10.1 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.7 |
2.7 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.7 |
2.7 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.7 |
6.6 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.7 |
1.3 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 0.7 |
1.3 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.7 |
1.3 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.7 |
4.6 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.7 |
5.3 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.6 |
1.9 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.6 |
1.3 |
GO:0072138 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.6 |
1.9 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.6 |
1.9 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.6 |
3.2 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.6 |
5.0 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.6 |
9.4 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.6 |
0.6 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.6 |
2.5 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.6 |
4.3 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.6 |
3.7 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.6 |
2.4 |
GO:0070814 |
hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.6 |
6.7 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.6 |
3.7 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.6 |
2.4 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.6 |
13.4 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.6 |
3.0 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.6 |
1.8 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.6 |
1.8 |
GO:1901563 |
response to camptothecin(GO:1901563) |
| 0.6 |
2.4 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 0.6 |
3.6 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.6 |
2.4 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.6 |
6.0 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.6 |
7.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.6 |
0.6 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.6 |
2.4 |
GO:0035878 |
nail development(GO:0035878) |
| 0.6 |
0.6 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.6 |
0.6 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.6 |
3.5 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.6 |
4.7 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.6 |
1.8 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.6 |
2.9 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.6 |
2.9 |
GO:0031652 |
positive regulation of heat generation(GO:0031652) |
| 0.6 |
1.7 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.6 |
2.9 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.6 |
2.3 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.6 |
1.7 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.6 |
2.9 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.6 |
1.1 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.6 |
2.3 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.6 |
1.7 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.6 |
0.6 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.6 |
1.7 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.6 |
3.9 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.6 |
1.7 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.6 |
2.8 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.6 |
1.1 |
GO:0036363 |
transforming growth factor beta activation(GO:0036363) |
| 0.6 |
1.7 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.6 |
4.4 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.5 |
2.7 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.5 |
4.9 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.5 |
1.1 |
GO:0009814 |
defense response, incompatible interaction(GO:0009814) |
| 0.5 |
5.4 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.5 |
2.2 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.5 |
5.4 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.5 |
2.1 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.5 |
0.5 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.5 |
2.6 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.5 |
1.6 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.5 |
1.1 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.5 |
7.9 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.5 |
1.6 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.5 |
2.1 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.5 |
1.6 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.5 |
10.4 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.5 |
0.5 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.5 |
4.7 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.5 |
1.5 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.5 |
1.5 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.5 |
1.5 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.5 |
4.1 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.5 |
1.5 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.5 |
3.6 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
| 0.5 |
0.5 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.5 |
2.0 |
GO:0072362 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.5 |
3.0 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) |
| 0.5 |
16.9 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.5 |
2.0 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.5 |
2.0 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.5 |
2.0 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.5 |
0.5 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.5 |
1.5 |
GO:0010641 |
positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.5 |
0.5 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.5 |
2.4 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.5 |
2.9 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.5 |
1.9 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.5 |
1.9 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.5 |
1.5 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.5 |
9.6 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.5 |
0.5 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.5 |
0.5 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.5 |
8.1 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.5 |
4.3 |
GO:0019827 |
stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
| 0.5 |
2.4 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.5 |
1.4 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.5 |
2.8 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.5 |
1.4 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.5 |
0.9 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.5 |
2.8 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.5 |
3.8 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.5 |
0.5 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.5 |
1.4 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.5 |
14.0 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.5 |
0.5 |
GO:0071679 |
commissural neuron axon guidance(GO:0071679) |
| 0.5 |
0.5 |
GO:1904884 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.5 |
3.7 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.5 |
1.8 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.5 |
12.0 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.5 |
0.5 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.5 |
3.7 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.5 |
0.5 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.5 |
1.4 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.5 |
0.5 |
GO:0048669 |
collateral sprouting in absence of injury(GO:0048669) |
| 0.5 |
5.0 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.5 |
4.5 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.5 |
0.5 |
GO:0060442 |
branching involved in prostate gland morphogenesis(GO:0060442) |
| 0.5 |
2.3 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) |
| 0.5 |
5.0 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.4 |
16.5 |
GO:0001738 |
morphogenesis of a polarized epithelium(GO:0001738) |
| 0.4 |
9.4 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.4 |
1.3 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.4 |
1.8 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.4 |
4.4 |
GO:0021983 |
pituitary gland development(GO:0021983) |
| 0.4 |
0.9 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.4 |
2.2 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.4 |
0.4 |
GO:1903321 |
negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
| 0.4 |
3.5 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.4 |
3.9 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.4 |
1.3 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.4 |
2.6 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.4 |
1.7 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.4 |
0.4 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.4 |
3.5 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.4 |
2.2 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.4 |
0.9 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.4 |
1.7 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.4 |
0.8 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.4 |
1.3 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.4 |
1.3 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.4 |
1.3 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.4 |
0.8 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.4 |
0.4 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.4 |
1.7 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.4 |
5.0 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.4 |
5.8 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.4 |
0.4 |
GO:0090259 |
regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.4 |
3.3 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.4 |
4.1 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.4 |
2.0 |
GO:0035745 |
T-helper 2 cell cytokine production(GO:0035745) |
| 0.4 |
2.4 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.4 |
0.8 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.4 |
0.4 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.4 |
2.8 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.4 |
2.0 |
GO:0098706 |
ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.4 |
8.5 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) |
| 0.4 |
8.9 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.4 |
2.4 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.4 |
1.2 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.4 |
0.8 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.4 |
0.4 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.4 |
1.2 |
GO:0019732 |
antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
| 0.4 |
4.0 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.4 |
0.8 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.4 |
1.2 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.4 |
0.4 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.4 |
0.8 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.4 |
0.8 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.4 |
3.2 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.4 |
0.8 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.4 |
1.6 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 |
2.4 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.4 |
2.4 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.4 |
2.7 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.4 |
3.5 |
GO:0036119 |
response to platelet-derived growth factor(GO:0036119) |
| 0.4 |
1.6 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.4 |
2.3 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.4 |
3.9 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.4 |
1.2 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.4 |
0.8 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.4 |
0.4 |
GO:0045605 |
negative regulation of epidermal cell differentiation(GO:0045605) |
| 0.4 |
1.5 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.4 |
5.7 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.4 |
1.9 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.4 |
1.1 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.4 |
1.9 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.4 |
2.7 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.4 |
1.9 |
GO:0010990 |
regulation of SMAD protein complex assembly(GO:0010990) |
| 0.4 |
4.2 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.4 |
1.1 |
GO:0090649 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.4 |
1.1 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) establishment of mitotic spindle localization(GO:0040001) |
| 0.4 |
6.7 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.4 |
1.5 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.4 |
0.7 |
GO:1902566 |
regulation of eosinophil activation(GO:1902566) |
| 0.4 |
2.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.4 |
2.5 |
GO:2000178 |
negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.4 |
2.2 |
GO:0006534 |
cysteine metabolic process(GO:0006534) |
| 0.4 |
0.7 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.4 |
0.4 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) |
| 0.4 |
1.4 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.4 |
4.6 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.4 |
1.4 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.4 |
2.5 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.4 |
2.1 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.4 |
0.7 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.4 |
2.1 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.4 |
2.1 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.4 |
1.1 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.4 |
0.7 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.4 |
0.4 |
GO:1902730 |
positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.4 |
0.4 |
GO:0021702 |
cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.4 |
0.4 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.3 |
1.7 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.3 |
0.3 |
GO:0021932 |
hindbrain radial glia guided cell migration(GO:0021932) |
| 0.3 |
1.0 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.3 |
0.3 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.3 |
1.0 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.3 |
0.7 |
GO:0035089 |
establishment of apical/basal cell polarity(GO:0035089) |
| 0.3 |
1.0 |
GO:0045006 |
DNA deamination(GO:0045006) |
| 0.3 |
1.0 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.3 |
2.1 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.3 |
1.0 |
GO:0000966 |
RNA 5'-end processing(GO:0000966) |
| 0.3 |
0.3 |
GO:0003211 |
cardiac ventricle formation(GO:0003211) |
| 0.3 |
2.7 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 |
3.4 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.3 |
1.7 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.3 |
1.3 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.3 |
1.0 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.3 |
1.0 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.3 |
3.3 |
GO:2000269 |
regulation of fibroblast apoptotic process(GO:2000269) |
| 0.3 |
0.7 |
GO:0050869 |
negative regulation of B cell activation(GO:0050869) |
| 0.3 |
0.7 |
GO:1902524 |
interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.3 |
2.3 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.3 |
1.6 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.3 |
1.0 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.3 |
1.0 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.3 |
0.7 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.3 |
2.6 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.3 |
2.0 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.3 |
1.9 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.3 |
0.6 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.3 |
1.6 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.3 |
0.6 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.3 |
1.9 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.3 |
1.6 |
GO:0090103 |
cochlea morphogenesis(GO:0090103) |
| 0.3 |
1.3 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.3 |
1.3 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.3 |
1.0 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.3 |
10.4 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.3 |
1.6 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.3 |
5.7 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.3 |
0.3 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.3 |
0.9 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.3 |
0.6 |
GO:0071772 |
response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
| 0.3 |
1.2 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.3 |
1.9 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.3 |
0.6 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.3 |
1.5 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.3 |
1.2 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.3 |
1.2 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.3 |
3.7 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.3 |
0.3 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.3 |
0.3 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.3 |
0.9 |
GO:1901072 |
glucosamine-containing compound catabolic process(GO:1901072) |
| 0.3 |
0.6 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.3 |
0.9 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.3 |
0.6 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.3 |
1.2 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.3 |
0.6 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
| 0.3 |
1.8 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.3 |
1.5 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.3 |
0.9 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.3 |
1.5 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.3 |
5.2 |
GO:0035567 |
non-canonical Wnt signaling pathway(GO:0035567) |
| 0.3 |
2.7 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.3 |
0.3 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.3 |
6.6 |
GO:0006336 |
DNA replication-independent nucleosome assembly(GO:0006336) |
| 0.3 |
0.6 |
GO:2000659 |
regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.3 |
2.4 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.3 |
0.6 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 0.3 |
0.9 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.3 |
1.8 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.3 |
0.9 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.3 |
6.5 |
GO:0003382 |
epithelial cell morphogenesis(GO:0003382) |
| 0.3 |
2.1 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.3 |
0.6 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.3 |
1.8 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.3 |
1.8 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.3 |
0.6 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.3 |
0.3 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.3 |
0.9 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.3 |
5.8 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.3 |
0.6 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.3 |
4.6 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.3 |
2.0 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.3 |
2.0 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.3 |
0.3 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.3 |
1.7 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.3 |
1.4 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.3 |
4.8 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.3 |
1.1 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.3 |
0.3 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.3 |
0.6 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.3 |
1.1 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.3 |
8.6 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.3 |
1.4 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.3 |
0.8 |
GO:1904569 |
regulation of selenocysteine incorporation(GO:1904569) |
| 0.3 |
0.8 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.3 |
1.4 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.3 |
8.8 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.3 |
5.0 |
GO:0009994 |
oocyte differentiation(GO:0009994) |
| 0.3 |
0.6 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.3 |
0.3 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.3 |
0.5 |
GO:1902741 |
type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.3 |
1.6 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.3 |
0.3 |
GO:0032922 |
circadian regulation of gene expression(GO:0032922) |
| 0.3 |
2.5 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.3 |
0.3 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.3 |
0.8 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) |
| 0.3 |
2.1 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.3 |
1.3 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.3 |
2.7 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.3 |
2.7 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.3 |
1.1 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.3 |
4.0 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.3 |
0.8 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.3 |
2.7 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.3 |
0.8 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.3 |
2.6 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.3 |
0.8 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.3 |
1.1 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.3 |
2.4 |
GO:0032048 |
cardiolipin metabolic process(GO:0032048) |
| 0.3 |
0.8 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.3 |
0.3 |
GO:0045188 |
regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.3 |
0.8 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.3 |
1.0 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.3 |
2.6 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.3 |
1.3 |
GO:0016572 |
histone phosphorylation(GO:0016572) |
| 0.3 |
1.8 |
GO:0019363 |
pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.3 |
0.8 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.3 |
2.6 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.3 |
0.5 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.3 |
0.3 |
GO:0060455 |
regulation of gastric acid secretion(GO:0060453) negative regulation of gastric acid secretion(GO:0060455) |
| 0.3 |
2.6 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.3 |
3.6 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.3 |
0.5 |
GO:0009215 |
purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
| 0.3 |
2.3 |
GO:0008105 |
asymmetric protein localization(GO:0008105) |
| 0.3 |
1.5 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.3 |
3.6 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.3 |
0.5 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.3 |
1.5 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.3 |
4.3 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.3 |
0.5 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.2 |
3.7 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.2 |
0.2 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.2 |
0.2 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.2 |
0.2 |
GO:0009113 |
purine nucleobase biosynthetic process(GO:0009113) |
| 0.2 |
0.7 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.2 |
1.7 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.2 |
1.0 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.2 |
0.7 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.2 |
1.9 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.2 |
0.7 |
GO:0030327 |
sulfur amino acid catabolic process(GO:0000098) prenylated protein catabolic process(GO:0030327) |
| 0.2 |
0.7 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 0.2 |
6.7 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.2 |
1.9 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.2 |
0.7 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.2 |
0.5 |
GO:0032493 |
response to bacterial lipoprotein(GO:0032493) |
| 0.2 |
0.2 |
GO:0042100 |
B cell proliferation(GO:0042100) |
| 0.2 |
0.9 |
GO:0080144 |
amino acid homeostasis(GO:0080144) |
| 0.2 |
0.7 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.2 |
0.7 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.2 |
1.2 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.2 |
0.5 |
GO:0014009 |
glial cell proliferation(GO:0014009) |
| 0.2 |
0.5 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.2 |
0.9 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.2 |
1.4 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.2 |
4.1 |
GO:2000779 |
regulation of double-strand break repair(GO:2000779) |
| 0.2 |
5.7 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.2 |
0.5 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.2 |
2.7 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.2 |
0.5 |
GO:0030330 |
DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 0.2 |
9.5 |
GO:0032648 |
regulation of interferon-beta production(GO:0032648) |
| 0.2 |
2.0 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.2 |
0.2 |
GO:0015822 |
ornithine transport(GO:0015822) |
| 0.2 |
0.5 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.2 |
1.1 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.2 |
3.6 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.2 |
1.1 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.2 |
1.1 |
GO:0010389 |
regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.2 |
0.4 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.2 |
0.7 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.2 |
1.1 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.2 |
2.0 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
3.5 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.2 |
0.4 |
GO:1902065 |
response to L-glutamate(GO:1902065) |
| 0.2 |
0.9 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.2 |
1.1 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.2 |
0.7 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 |
0.2 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.2 |
3.0 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.2 |
1.7 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.2 |
0.6 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
| 0.2 |
1.3 |
GO:0006691 |
leukotriene metabolic process(GO:0006691) |
| 0.2 |
0.9 |
GO:1904923 |
regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
| 0.2 |
0.2 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.2 |
1.1 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.2 |
0.8 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.2 |
0.4 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 |
0.6 |
GO:0003283 |
atrial septum development(GO:0003283) |
| 0.2 |
0.4 |
GO:0061013 |
regulation of mRNA catabolic process(GO:0061013) positive regulation of mRNA catabolic process(GO:0061014) |
| 0.2 |
0.4 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 |
0.8 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.2 |
0.4 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 |
1.2 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.2 |
0.2 |
GO:0009445 |
putrescine metabolic process(GO:0009445) |
| 0.2 |
1.0 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.2 |
0.4 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.2 |
0.2 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.2 |
0.4 |
GO:0009411 |
response to UV(GO:0009411) |
| 0.2 |
0.4 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 |
0.8 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.2 |
0.4 |
GO:0051657 |
maintenance of organelle location(GO:0051657) |
| 0.2 |
2.2 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.2 |
0.2 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.2 |
0.6 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.2 |
2.2 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.2 |
0.4 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.2 |
0.2 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.2 |
1.8 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.2 |
1.8 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.2 |
1.2 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.2 |
0.4 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.2 |
0.4 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.2 |
2.5 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.2 |
0.4 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.2 |
0.6 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.2 |
1.6 |
GO:0090224 |
regulation of spindle organization(GO:0090224) |
| 0.2 |
0.4 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.2 |
1.2 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.2 |
0.4 |
GO:0060430 |
lung saccule development(GO:0060430) |
| 0.2 |
2.1 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.2 |
0.4 |
GO:1904659 |
glucose transmembrane transport(GO:1904659) |
| 0.2 |
0.8 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
| 0.2 |
1.7 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.2 |
1.9 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.2 |
0.2 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 |
0.6 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 |
1.0 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 |
0.8 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.2 |
2.3 |
GO:0046036 |
CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.2 |
0.4 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.2 |
3.0 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.2 |
9.6 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.2 |
0.7 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.2 |
0.4 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.2 |
0.9 |
GO:0098869 |
cellular oxidant detoxification(GO:0098869) |
| 0.2 |
0.4 |
GO:0035934 |
corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.2 |
0.7 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.2 |
0.6 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.2 |
0.9 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.2 |
2.7 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.2 |
1.5 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.2 |
0.9 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
0.4 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.2 |
0.9 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.2 |
0.5 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.2 |
0.7 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.2 |
0.5 |
GO:0045830 |
positive regulation of isotype switching(GO:0045830) |
| 0.2 |
0.7 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.2 |
0.7 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.2 |
0.7 |
GO:0072272 |
proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.2 |
0.4 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.2 |
0.7 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.2 |
1.2 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.2 |
2.3 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 |
0.9 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.2 |
0.2 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.2 |
0.2 |
GO:0009208 |
pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
| 0.2 |
3.3 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.2 |
0.7 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.2 |
0.2 |
GO:1901620 |
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.2 |
0.5 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.2 |
0.9 |
GO:0071404 |
cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
| 0.2 |
0.7 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
| 0.2 |
0.3 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.2 |
0.5 |
GO:0019389 |
glucuronoside metabolic process(GO:0019389) |
| 0.2 |
1.0 |
GO:1902750 |
negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.2 |
0.7 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.2 |
0.5 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.2 |
0.2 |
GO:1901796 |
regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.2 |
0.7 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 |
0.5 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.2 |
1.2 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 |
0.5 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.2 |
1.5 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.2 |
3.1 |
GO:0048538 |
thymus development(GO:0048538) |
| 0.2 |
0.3 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.2 |
0.3 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.2 |
1.1 |
GO:0039529 |
RIG-I signaling pathway(GO:0039529) |
| 0.2 |
1.6 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.2 |
0.3 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.2 |
2.1 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 |
0.6 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.2 |
0.5 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.2 |
0.5 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 |
0.6 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.2 |
0.6 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.2 |
7.1 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.2 |
0.5 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.2 |
0.3 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.2 |
0.3 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.2 |
1.2 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 |
2.8 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.2 |
0.3 |
GO:2000851 |
positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.2 |
0.9 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.2 |
1.5 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.2 |
0.2 |
GO:2000121 |
regulation of removal of superoxide radicals(GO:2000121) |
| 0.2 |
0.9 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.2 |
1.1 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.2 |
0.2 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.2 |
0.5 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.2 |
1.1 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.2 |
1.4 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.2 |
0.3 |
GO:1990839 |
response to endothelin(GO:1990839) |
| 0.2 |
2.0 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.2 |
0.6 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.2 |
0.8 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 |
0.2 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.2 |
0.8 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 |
0.3 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.2 |
0.3 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.2 |
1.8 |
GO:0042044 |
fluid transport(GO:0042044) |
| 0.2 |
0.5 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.1 |
0.1 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 |
1.0 |
GO:0061732 |
acetyl-CoA biosynthetic process from pyruvate(GO:0006086) mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 |
0.3 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
0.1 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.1 |
0.3 |
GO:0071455 |
cellular response to hyperoxia(GO:0071455) |
| 0.1 |
0.4 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.1 |
1.9 |
GO:0001841 |
neural tube formation(GO:0001841) |
| 0.1 |
0.7 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.1 |
2.9 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
0.4 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.1 |
0.6 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.1 |
1.0 |
GO:0006551 |
leucine metabolic process(GO:0006551) |
| 0.1 |
0.9 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.1 |
0.6 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
1.8 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
0.1 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.1 |
0.4 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
| 0.1 |
0.4 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.1 |
0.4 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.1 |
0.6 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
| 0.1 |
0.3 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
0.4 |
GO:0032682 |
negative regulation of chemokine production(GO:0032682) |
| 0.1 |
0.6 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
0.6 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 |
1.2 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.1 |
0.1 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.1 |
1.4 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
1.5 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 |
3.4 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.1 |
1.2 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 |
0.9 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.1 |
0.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.3 |
GO:0051006 |
positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.1 |
0.3 |
GO:0016573 |
histone acetylation(GO:0016573) |
| 0.1 |
0.5 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.5 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
0.8 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
0.5 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
1.8 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.5 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.1 |
0.5 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 |
0.7 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 |
0.9 |
GO:0009437 |
amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
| 0.1 |
0.9 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.4 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.1 |
0.1 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
0.5 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
0.9 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.1 |
1.0 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 |
8.6 |
GO:0036503 |
ERAD pathway(GO:0036503) |
| 0.1 |
0.8 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
0.3 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) negative regulation of tumor necrosis factor secretion(GO:1904468) |
| 0.1 |
0.8 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.3 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.1 |
0.4 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 |
0.1 |
GO:0022028 |
tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
| 0.1 |
0.4 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.1 |
0.8 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.1 |
0.6 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 |
2.4 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.1 |
0.4 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
1.1 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 |
0.1 |
GO:1902623 |
negative regulation of neutrophil migration(GO:1902623) |
| 0.1 |
0.2 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
1.1 |
GO:0007093 |
mitotic cell cycle checkpoint(GO:0007093) |
| 0.1 |
0.9 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
1.5 |
GO:0006997 |
nucleus organization(GO:0006997) |
| 0.1 |
0.5 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.4 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 |
0.6 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 |
1.2 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 |
0.2 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
0.4 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.1 |
0.4 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.6 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 |
1.0 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.1 |
1.9 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.1 |
0.8 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.1 |
0.5 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
0.8 |
GO:0031018 |
endocrine pancreas development(GO:0031018) |
| 0.1 |
0.1 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) |
| 0.1 |
1.1 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
0.2 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.1 |
GO:0042637 |
catagen(GO:0042637) |
| 0.1 |
0.2 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 |
0.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
1.1 |
GO:0035909 |
aorta morphogenesis(GO:0035909) |
| 0.1 |
0.3 |
GO:0048844 |
artery morphogenesis(GO:0048844) |
| 0.1 |
1.1 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.1 |
0.2 |
GO:1903371 |
regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.1 |
5.0 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.1 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.1 |
0.2 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.1 |
0.2 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
0.3 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 |
1.3 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.4 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.1 |
0.7 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
0.1 |
GO:0001788 |
antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.1 |
0.9 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.1 |
3.9 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 |
0.7 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.1 |
0.5 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
0.1 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 0.1 |
0.4 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.9 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.3 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.2 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.1 |
0.2 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.1 |
0.2 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
0.5 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.1 |
0.2 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.1 |
2.0 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
| 0.1 |
0.4 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.1 |
0.3 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.1 |
0.2 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
1.3 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.3 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
0.1 |
GO:1904959 |
regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
| 0.1 |
0.3 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.1 |
0.5 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.1 |
0.3 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.1 |
0.2 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.1 |
2.0 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.1 |
1.5 |
GO:0060324 |
face development(GO:0060324) |
| 0.1 |
2.6 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.1 |
0.1 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.1 |
0.3 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.1 |
0.8 |
GO:0048747 |
muscle fiber development(GO:0048747) |
| 0.1 |
0.5 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.1 |
0.4 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.5 |
GO:0014742 |
positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.1 |
0.1 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
0.4 |
GO:0072584 |
caveolin-mediated endocytosis(GO:0072584) |
| 0.1 |
0.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
0.4 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
0.6 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 |
1.9 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
0.4 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
1.2 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.1 |
0.1 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) |
| 0.1 |
2.7 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.2 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
0.2 |
GO:1903429 |
regulation of cell maturation(GO:1903429) |
| 0.1 |
0.6 |
GO:1901623 |
regulation of lymphocyte chemotaxis(GO:1901623) |
| 0.1 |
0.5 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.1 |
0.7 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.1 |
1.3 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.7 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 |
0.7 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.1 |
2.5 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 |
0.7 |
GO:0030850 |
prostate gland development(GO:0030850) |
| 0.1 |
0.2 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.1 |
6.2 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.1 |
0.3 |
GO:0019244 |
lactate biosynthetic process from pyruvate(GO:0019244) |
| 0.1 |
0.3 |
GO:0071346 |
cellular response to interferon-gamma(GO:0071346) |
| 0.1 |
0.6 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.4 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 |
0.9 |
GO:0031663 |
lipopolysaccharide-mediated signaling pathway(GO:0031663) |
| 0.1 |
1.1 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.1 |
0.9 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.6 |
GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.1 |
1.1 |
GO:1904355 |
regulation of telomere capping(GO:1904353) positive regulation of telomere capping(GO:1904355) |
| 0.1 |
0.9 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
0.5 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.1 |
0.6 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.1 |
0.2 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.3 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) |
| 0.1 |
0.2 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.6 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.1 |
GO:0043368 |
positive T cell selection(GO:0043368) |
| 0.1 |
0.1 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
0.5 |
GO:0042098 |
T cell proliferation(GO:0042098) |
| 0.1 |
1.7 |
GO:0051497 |
negative regulation of stress fiber assembly(GO:0051497) |
| 0.1 |
0.1 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.2 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.1 |
0.5 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.1 |
0.1 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
| 0.1 |
0.1 |
GO:0001562 |
response to protozoan(GO:0001562) |
| 0.1 |
0.2 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
1.2 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.8 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 |
3.1 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.1 |
0.1 |
GO:0090085 |
regulation of protein deubiquitination(GO:0090085) |
| 0.1 |
0.5 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
0.3 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.1 |
0.1 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
0.5 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
0.3 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
0.3 |
GO:0006720 |
isoprenoid metabolic process(GO:0006720) |
| 0.1 |
0.5 |
GO:1902622 |
regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
| 0.1 |
0.1 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.1 |
0.3 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
1.0 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
| 0.1 |
0.3 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.1 |
0.1 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
1.9 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.1 |
0.3 |
GO:1903286 |
regulation of potassium ion import(GO:1903286) |
| 0.1 |
0.1 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
0.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.1 |
0.1 |
GO:2000192 |
negative regulation of fatty acid transport(GO:2000192) |
| 0.1 |
2.0 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.1 |
0.1 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.1 |
0.2 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.1 |
0.2 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.3 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.1 |
0.2 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 |
0.2 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.3 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.1 |
0.4 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.1 |
0.1 |
GO:0001824 |
blastocyst development(GO:0001824) |
| 0.1 |
1.8 |
GO:0050868 |
negative regulation of T cell activation(GO:0050868) |
| 0.1 |
0.1 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
0.5 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
0.3 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 |
0.2 |
GO:1901992 |
positive regulation of mitotic cell cycle phase transition(GO:1901992) |
| 0.1 |
0.3 |
GO:0051461 |
corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.1 |
0.4 |
GO:0008334 |
histone mRNA metabolic process(GO:0008334) |
| 0.1 |
0.1 |
GO:1903332 |
regulation of protein folding(GO:1903332) |
| 0.1 |
0.2 |
GO:0032228 |
regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.0 |
2.7 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.1 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.0 |
0.3 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.4 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.0 |
0.1 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.0 |
0.3 |
GO:0071174 |
negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) |
| 0.0 |
0.2 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.0 |
0.2 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.9 |
GO:0047497 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.0 |
0.0 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
11.9 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.0 |
0.2 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.0 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.0 |
0.4 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.0 |
1.4 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.0 |
0.1 |
GO:1904245 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.0 |
0.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.2 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.0 |
0.1 |
GO:0060468 |
prevention of polyspermy(GO:0060468) |
| 0.0 |
0.2 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 |
0.1 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 |
0.1 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 |
1.6 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
0.4 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.0 |
0.1 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.0 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.0 |
0.0 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.0 |
0.8 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 |
0.1 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 |
0.3 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 |
0.1 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.0 |
0.2 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.1 |
GO:0090467 |
L-arginine import(GO:0043091) arginine import(GO:0090467) |
| 0.0 |
0.2 |
GO:0070849 |
response to epidermal growth factor(GO:0070849) |
| 0.0 |
0.2 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.0 |
0.2 |
GO:0032435 |
negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.0 |
0.2 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.1 |
GO:0002507 |
tolerance induction(GO:0002507) |
| 0.0 |
0.2 |
GO:0046500 |
S-adenosylmethionine metabolic process(GO:0046500) |
| 0.0 |
0.9 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.2 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.5 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.0 |
0.1 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.1 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 |
0.2 |
GO:0016093 |
polyprenol metabolic process(GO:0016093) |
| 0.0 |
0.1 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 |
0.2 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.0 |
0.4 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.0 |
0.1 |
GO:0015744 |
succinate transport(GO:0015744) |
| 0.0 |
0.1 |
GO:2000177 |
regulation of neural precursor cell proliferation(GO:2000177) |
| 0.0 |
0.1 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.0 |
0.4 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.1 |
GO:0030952 |
establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.0 |
0.2 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.0 |
0.1 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.0 |
0.3 |
GO:1903077 |
negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.0 |
0.0 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.0 |
0.7 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.1 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 |
0.4 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.0 |
0.1 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.0 |
0.1 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.0 |
0.1 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.0 |
0.4 |
GO:0051881 |
regulation of mitochondrial membrane potential(GO:0051881) |
| 0.0 |
0.2 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 |
0.4 |
GO:0002066 |
columnar/cuboidal epithelial cell development(GO:0002066) |
| 0.0 |
0.1 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.2 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.1 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.0 |
0.1 |
GO:0050688 |
regulation of defense response to virus(GO:0050688) |
| 0.0 |
0.1 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.0 |
0.0 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.0 |
0.1 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.0 |
0.0 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.0 |
0.3 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.0 |
0.0 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.0 |
1.1 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.0 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.0 |
0.0 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.0 |
0.1 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.0 |
GO:0048687 |
positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 0.0 |
0.1 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 |
0.1 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.0 |
0.1 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.0 |
0.5 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.0 |
0.1 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.0 |
1.1 |
GO:0005976 |
polysaccharide metabolic process(GO:0005976) |
| 0.0 |
0.0 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.0 |
0.1 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.1 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.1 |
GO:0046326 |
positive regulation of glucose import(GO:0046326) |
| 0.0 |
0.1 |
GO:0010574 |
regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.0 |
0.0 |
GO:0032392 |
DNA geometric change(GO:0032392) |
| 0.0 |
0.0 |
GO:0060602 |
branch elongation of an epithelium(GO:0060602) |
| 0.0 |
0.0 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.1 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.0 |
0.0 |
GO:0060395 |
SMAD protein signal transduction(GO:0060395) |
| 0.0 |
0.0 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.0 |
0.1 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.0 |
0.0 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.0 |
0.1 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.0 |
0.1 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.0 |
0.2 |
GO:0031960 |
response to corticosteroid(GO:0031960) response to glucocorticoid(GO:0051384) |
| 0.0 |
0.0 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) |
| 0.0 |
0.0 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.0 |
0.0 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.0 |
GO:0006573 |
valine metabolic process(GO:0006573) |
| 0.0 |
0.1 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
